Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals

This study has been completed.
Sponsor:
Collaborator:
National Institute of Mental Health (NIMH)
Information provided by (Responsible Party):
University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT00428519
First received: January 26, 2007
Last updated: June 2, 2016
Last verified: June 2016